Clinical Trial Update: Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hydroxychloroquine with azithromycin for preventing hospitalization or death in COVID-19; terminated with posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2

Drugs mentioned

• Azithromycin (azithromycin)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: COVID-19, SARS-CoV 2 | Phase 2 | Status: TERMINATED | Results posted: 2021-04-01